|
|
Volumn 5, Issue , 2001, Pages 163-166
|
|
New antidepressive and antipsychotic drugs in juvenile neuronal ceroid lipofuscinoses - A pilot study
a a a a |
|
Author keywords
JNCL; Psychiatric symptoms; SSRI; Therapy; Typical antipsychotics
|
|
Indexed keywords
ANTIDEPRESSANT AGENT;
CITALOPRAM;
NEUROLEPTIC AGENT;
OLANZAPINE;
PSYCHOTROPIC AGENT;
QUETIAPINE;
RISPERIDONE;
ADOLESCENT;
ADULT;
ADVERSE DRUG REACTION;
AFFECTIVE NEUROSIS;
ANXIETY;
ARTICLE;
CHILD;
CLINICAL ARTICLE;
CLINICAL RESEARCH;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE SEVERITY;
DOSE RESPONSE;
DRUG DOSE;
DRUG EFFICACY;
DRUG SAFETY;
EXTRAPYRAMIDAL SYNDROME;
FATIGUE;
FEMALE;
FINLAND;
HUMAN;
INTERVIEW;
MALE;
MEDICAL INFORMATION;
MEDICAL RECORD;
MENTAL DISEASE;
NEURONAL CEROID LIPOFUSCINOSIS;
PARENT;
PHYSICIAN;
PILOT STUDY;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
PSYCHOSIS;
SIDE EFFECT;
SYMPTOM;
TREATMENT INDICATION;
TREATMENT OUTCOME;
WEIGHT GAIN;
ADOLESCENT;
ADULT;
ANTIDEPRESSIVE AGENTS, SECOND-GENERATION;
ANTIPSYCHOTIC AGENTS;
BENZODIAZEPINES;
CHILD;
CITALOPRAM;
DIBENZOTHIAZEPINES;
FEMALE;
HUMANS;
MALE;
NEURONAL CEROID-LIPOFUSCINOSES;
PILOT PROJECTS;
PIRENZEPINE;
RISPERIDONE;
|
|
EID: 0034912345
PISSN: 10903798
EISSN: None
Source Type: Journal
DOI: 10.1053/ejpn.2000.0455 Document Type: Article |
|
Times cited : (17)
|
|
References (13)
|
